Pro Research Updates
Our research updates, often shorter in length, are conveyed through initial and ongoing coverage of our catalog of stocks. With thousands of original research pieces and updates under our belt, we have an archival system of keeping the history of our coverage intact and easy to find. For examples of how you will receive this research please see a few case studies showing the chronology of a few notable stocks.
Below you can find the most recent stocks that we have issued original research on, or updates to original research.
Log in below with your Premium Account to see the most recent coverage.
The FULL list of Spotlight Research can be found HERE, which has years of coverage and updates – all archived for your reference. Feel free to use the Advanced Filter at that page to quickly find coverage on stock of interest.
Latest Stock Coverage
Luminar Media Group, Inc. (OTC:LRGR) ($0.55; $49.5M market cap) reported preliminary Q4 2025 operating metrics:
Seventh consecutive quarter of growth
Q4 2025 gross funding volume of $3.9 million vs. $1.86 million in the prior year, up 109% YoY
Q4 2025 receivable cash deposits of $3.5 million vs. $1.2 million in the prior year, up 191% YoY
Full-year 2025 gross funding volume of $12.3 milli...
Zoned Properties, Inc. (OTCQB:ZDPY) ($0.45; $5.3M market cap) announced execution of definitive agreements to sell and liquidate 100% of its assets and operations:
Entered into multiple definitive agreements to sell and liquidate 100% of the Company’s assets and operations for $16 million.
Agreements include:
$9 million exclusive option for sale of Arizona “CKG” properti...
**Call To Action: IVRO - An Extremely Speculative Idea We Are Adding to the Run to $1 Model Portfolio [PodClip]
Maj just dropped a new PodClip focused on Invitro International (OTCQB:IVRO), a tiny, extremely speculative, OTC name that sits in the non-animal testing niche. Think eye and skin irritation testing without using animal tissue. In the clip, he considers IVRO as a Run-to-$1 Radar idea: n...
Glucose Health, Inc. (OTC:GLUC) ($0.34; $5.9M market cap) announced a Note Settlement Agreement and strategic financial restructuring:
Confirmed Note Settlement Agreement with board member Edmund J. Burke, eliminating $225,000 in debt and converting it into 1.8 million shares of restricted common stock.
Approximately $30,000 in accrued interest was waived by Mr. Burke.
Mr. Burke voluntarily...
AmeraMex International, Inc. (OOTC:AMMX) ($0.13; $2.0M market cap) announced a shareholder update:
Estimated 2025 revenue of $15–16 million vs. $14.9M in 2024 and $13.4M in 202
Expected return to profitability in 2025 after net losses in the two previous years
Ongoing long-term rental relationship with U.S. Government
Increased RFP activity from logistics providers and distribution...
Viewing page 4 of 4|Previous Page